Cargando…

Sickle cell disease: looking back but towards the future

Detalles Bibliográficos
Autor principal:	Cançado, Rodolfo Delfini
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Hematologia e Hemoterapia 2012
Materias:	Scientific Comments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459630/ https://www.ncbi.nlm.nih.gov/pubmed/23049411 http://dx.doi.org/10.5581/1516-8484.20120041

Ejemplares similares

Comprehensive healthcare for individuals with sickle cell disease - a constant challenge
por: Cançado, Rodolfo Delfini
Publicado: (2011)

Blood donation, blood supply, iron deficiency and anemia - it is time to shift attention back to donor health
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2012)

Pyruvate kinase deficiency: novel mutations and a better understanding of the genotype-to-phenotype correlation in Brazilian patients()
por: Cançado, Rodolfo Delfini
Publicado: (2018)

Sexuality and sickle cell disease
por: Figueiredo, Maria Stella
Publicado: (2013)

Is sickle cell disease the same everywhere?
por: Hankins, Jane
Publicado: (2012)

Oxidative stress in sickle cell disease
por: Queiroz, Raphael Ferreira, et al.
Publicado: (2013)

Induction therapy and stem-cell mobilization in myeloma, look at the past to plan the future()
por: Schaffel, Rony
Publicado: (2019)

Comments on renal abnormalities of sickle cell disease
por: Abbud-Filho, Mario
Publicado: (2013)

Comment on sickle cell disease and left ventricular hypertrophy()
por: Verissimo, Monica Pinheiro de Almeida
Publicado: (2015)

An eye on sickle cell retinopathy()
por: de Melo, Mônica Barbosa
Publicado: (2014)

Dynamics of sickle cell disease as one of the determinants of quality of life
por: Ivo, Maria Lúcia, et al.
Publicado: (2013)

Oxidative status in sickle cell anemia
por: Magalhães, Silvia Maria Meira
Publicado: (2011)

Pregnancy in sickle cell disease – do we know what to expect?()
por: Fertrin, Kleber Yotsumoto
Publicado: (2014)

Sickle cell disease: from the beginning until it was recognized as a public health disease
por: Naoum, Paulo Cesar
Publicado: (2011)

The invisibility of sickle cell disease in Brazil: lessons from a study in Maranhão()
por: Viana, Marcos Borato
Publicado: (2015)

Nitric oxide status in sickle cell anemia
por: Gonçalves, Romélia Pinheiro
Publicado: (2012)

Comment on: “Oral health-related quality of life in children and teens with sickle cell disease”()
por: Correa, Maria Elvira Pizzigatti
Publicado: (2016)

Fetal hemoglobin and hemolysis markers in sickle cell anemia()
por: Colella, Marina Pereira, et al.
Publicado: (2015)

Comments on: molecular matching of red blood cells is superior to serological matching in sickle cell disease patients
por: Nance, Sandra Taddie, et al.
Publicado: (2013)

Comment on "The influence of hydroxyurea on oxidative stress in sickle cell anemia"
por: van Beers, Eduard Johannes, et al.
Publicado: (2012)

Sickle cell anemia: clinical diversity and beta S-globin haplotypes
por: Loggetto, Sandra Regina
Publicado: (2013)

Haptoglobin: an emerging candidate for phenotypic modulation of sickle cell anemia?()
por: Santos, Magnun Nueldo Nunes dos
Publicado: (2015)

Gene deletions of glutathione S-transferase and iron status in sickle cell patients
por: Zamaro, Paula Juliana Antoniazzo
Publicado: (2012)

The lab on lockdown: thinking back and looking ahead
por: Poe, Gina R., et al.
Publicado: (2020)

Comment on “Molecular analysis and association with clinical and laboratory manifestations in children with sickle cell anemia”()
por: Souza Goncalves, Marilda
Publicado: (2014)

Quality of life in sickle cell disease: assessments by the 36-item Short Form Health Survey Questionnaire and Beck Depression Inventory
por: Ivo, Maria Lucia, et al.
Publicado: (2012)

Comment on “Influence of βS-globin haplotypes and hydroxyurea on tumor necrosis factor-alpha levels in sickle cell anemia”
por: de Souza Torres, Lidiane
Publicado: (2014)

Comment on "The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea"
por: Souza, José Carlos, et al.
Publicado: (2012)

Comments on: "Impact of iron overload on interleukin-10 levels, biochemical parameters and oxidative stress in patients with sickle cell anemia"
por: Driss, Adel
Publicado: (2013)

A future without human leukocyte antigens?()
por: Gilli, Simone Cristina Olenscki
Publicado: (2018)

Prostate cancer grading, time to go back to the future
por: Egevad, Lars, et al.
Publicado: (2020)

Thiazides in chronic kidney disease: “back to the future”
por: de la Espriella, Rafael, et al.
Publicado: (2022)

Genetic polymorphisms, chronic lymphocytic leukemia, and the future: are we there yet?
por: Caimi, Paolo F., et al.
Publicado: (2014)

Anemia: winning elbow room in the field of hematology and hemotherapy
por: Cançado, Rodolfo Delfini
Publicado: (2012)

Iron deficiency anemia and its treatment - reply
por: Cançado, Rodolfo Delfini
Publicado: (2011)

A step towards the cure of Burkitt's lymphoma in developing countries
por: Klumb, Claudete Esteves
Publicado: (2012)

Estimated mortality rates of individuals with sickle cell disease in Brazil: real-world evidence
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2023)

Mitigating the effect of the COVID-19 pandemic on sickle cell disease services in African countries
por: Dexter, Daniel, et al.
Publicado: (2020)

Hematopoietic stem cell transplantation for Hodgkin's disease
por: Patah, Poliana, et al.
Publicado: (2011)

The SickleGenAfrica Network
por: Ofori-Acquah, Solomon F
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k4j1seoi5v532frop003gd983t